Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1B | P28222 | 7/20 | 0.58 |
| ▸ | HTR1D | P28221 | 5/20 | 0.58 |
| ▸ | HTR1A | P08908 | 2/20 | 0.55 |
| ▸ | HTR6 | P50406 | 7/20 | 0.53 |
| ▸ | NOS3 | P29474 | 4/20 | 0.51 |
| ▸ | NOS1 | P29475 | 4/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7006270 | 1.00 | HTR1B (0.58) | HTR1BHTR1DHTR1AHTR6NOS3 | |
| SCHEMBL7005001 | 0.82 | HTR1A (0.47) | HTR1BHTR1DHTR1AHTR6 | |
| SCHEMBL7006323 | 0.79 | CYP1A2 (0.55) | HTR1BHTR1DHTR1ANOS3NOS1 | |
| SCHEMBL7013305 | 0.77 | HTR6 (0.39) | HTR1BHTR1DHTR6NOS3NOS1 | |
| SCHEMBL7010382 | 0.77 | HTR6 (0.39) | HTR1BHTR1DHTR6NOS3NOS1 | |
| SCHEMBL8879229 | 0.75 | HTR1B (0.76) | HTR1BHTR1DHTR1AHTR6NOS3 | |
| SCHEMBL7464637 | 0.75 | HTR1B (0.76) | HTR1BHTR1DHTR1AHTR6NOS3 | |
| SCHEMBL8880205 | 0.75 | HTR1B (0.76) | HTR1BHTR1DHTR1AHTR6NOS3 | |
| SCHEMBL7006135 | 0.75 | HTR1B (0.62) | HTR1BHTR1DHTR1AHTR6NOS3 | |
| SCHEMBL7010984 | 0.75 | SLC6A4 (0.53) | NOS3NOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1098896-B1 | 5-BICYCLOINDOLE COMPOUNDS | NPS ALLELIX CORP (CA) | 2003-06-25 | — | — | EP | disclosed |
| US-6329390-B1 | BIHETEROCYCLIC INDOLES AS ANALGESICS AND NERVOUS SYSTEM DISORDERS | NPS ALLELIX CORP. (CA) | 2001-12-11 | — | — | US | disclosed |